ReviewJournal for immunotherapy of cancer2024

Merkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapy.

Tomoko Akaike et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.